In addition, maternal virilization (40.8%) is described in mothers during pregnancies of PORD fetus, and it is also due to placental aromatase (CYP19A1) deficiency [10]. The gene discussed is CYP19A1; the disease is congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency.